Middle East & Africa
Middle East & Africa Pharmaceuticals & Healthcare Insight provides country-by-country analysis of the key trends impacting the prescription, OTC and generic drugs industries across the Middle East & Africa. Middle East & Africa Pharmaceuticals & Healthcare Insight includes competitive intelligence on the growth strategies of leading national and multinational companies, along with 5-year industry forecasts for each country. The service includes access to the very latest analysis, a searchable archive of articles and data and the ability to download PDFs of current and back issues.
›› To gain FREE online access for 14 days and to download a FREE PDF, click trial.
›› To receive 15 monthly pdf issues for the price of 12 and to gain immediate online access, click subscribe.
Ethiopia / Industry
The potential for returns on pharmaceutical investment in Ethiopia are great given the large population, favourable demographic and epidemiological trends, as well as its position as a platform to expand into Kenya and Tanzania. However, we highlight the ease with which counterfeit medicines can enter the country due to its proximity to China and India and low per capita medicine...
2013-05-17Algeria / Industry
Although PhRMA is encouraged by the Algerian government's intention to improve its pharmaceutical policies, it is evident that the Ministry of Health continues to make the entire process...
2013-05-16Lebanon / Industry
BMI View: In Lebanon, poor intellectual property protection of innovative medicines is based on the ease with which the Ministry of Health allows generic equivalents to enter the market....
2013-05-15Industry Developments
Ethiopia
The potential for returns on pharmaceutical investment in Ethiopia are great given the large population, favourable demographic and epidemiological trends, as well as its position as...
2013-05-17Algeria
Although PhRMA is encouraged by the Algerian government's intention to improve its pharmaceutical policies, it is evident that the Ministry of Health continues to make the entire process...
2013-05-16Lebanon
BMI View: In Lebanon, poor intellectual property protection of innovative medicines is based on the ease with which the Ministry of Health allows generic equivalents to enter the market....
2013-05-15South Africa
BMI View: Increasing competition in the bid to partially or completely buy out South African drugmaker Adcock Ingram, as well as strong revenue growth outlooks for the company in 2013...
2013-05-14
